Skip to main content
Premium Trial:

Request an Annual Quote

Hexagon Bio Raises $47M in Series A Round

NEW YORK — Drug discovery firm Hexagon Bio said on Tuesday that it has raised $47 million in a Series A financing round.

The round was led by The Column Group and included 8VC and Two Sigma Ventures. In conjunction with the round, The Column Group's David Goeddel has been named chairman of Hexagon.

Hexagon's discovery platform is designed to identify potentially therapeutic secondary metabolites and their protein targets directly from fungal genomes. The Menlo Park, California-based company said it has developed an algorithm called Ticker to identify human targets of these secondary metabolites and a synthetic biology platform called Hex for the expression of fungal biosynthetic genes and their encoded metabolites in Saccharomyces cerevisiae.

Details about the Hex platform were reported in Science Advances in 2018.

Hexagon said it will use the Series A funding to develop a proprietary genomics database of new secondary metabolites and hire a drug discovery team to develop these compounds into drugs, with an initial focus on cancer and infectious disease.

"Hexagon has shown that we can build small molecules targeting key proteins in human disease using our database of microbial genomes," Hexagon CEO Maureen Hillenmeyer said in a statement. "Now it's time to scale up, and Hexagon is exceptionally well poised to do so using automation and large-scale DNA sequencing of microbes starting with fungi."

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.